We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Antisoma | LSE:ASM | London | Ordinary Share | GB0055696032 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.325 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
31/10/2013 16:22 | Unlikely considering its changing purpose to an investment company! | fenners66 | |
31/10/2013 09:40 | What a sorry state of affairs. 2006 -2007 went from 12 p to 60p on possible good medical results. Antisoma tried real hard to crack the cancer blight, real pity it failed. At least they really had a good go at it. OXB 5p to 50p same,wife of ceo sold her total holding at 54p after that I never went back in. There is a huge failure list but I did believe in the possible good outcome of quite a few of these research stocks, as like so many of us we have lost loved ones to this terrible disease We live in hope. ASM might just develop a game changer yet. | minho | |
16/10/2013 13:56 | Antisoma PLC is proposing to change its name to Sarossa Capital PLC. | palwing13 | |
02/10/2013 09:54 | Summit Tel: +44 (0)1235 443 951 Glyn Edwards / Richard Pye +44 (0)7825 313 476 Cairn Financial Advisers Same guy? Edwards I mean. I held these a few years back, got out at a loss, somewhat higher than this! | rayrac | |
02/10/2013 06:44 | There's life yet.hTTp://www.an ADVFN competitor.com/actio | palwing13 | |
12/9/2013 13:25 | Do keep up Watson! | jsbach123 | |
04/9/2013 08:43 | Another small cap pharma biotech in trouble Only 1 in 10 make it to profitability picking the ones that do or might ain't easy Taken me 5 years | buywell2 | |
09/3/2013 14:48 | Nice chart. | freddie ferret | |
19/2/2013 15:12 | Not the Antisoma we once knew, gamboling by George! Mind you there is money in gamboling! | freddie ferret | |
19/2/2013 14:52 | Yippeee 2p | jsbach123 | |
20/12/2012 19:14 | 20 December 2012 Antisoma plc ("Antisoma") Agreement with GVC Holdings plc ("GVC") The Directors announce that on 20 December 2012, Antisoma entered into an agreement to subscribe, as described below, up to GBP4.0 million of new ordinary shares proposed to be issued by GVC in connection with its recommended offer, together with William Hill Australia Pty Limited ("William Hill"), for Sportingbet plc ("Sportingbet") (the "Offer"), which was announced today. GVC has offered as consideration, for the businesses of Sportingbet which it proposes to acquire and retain, 29.0 million new GVC ordinary shares with a value of approximately GBP67.7 million at 233.5p per share, being the closing price on 15 October 2012, the last business day prior to the suspension of trading in GVC shares. Sportingbet shareholders are also being offered cash financed through a payment by William Hill in relation to the businesses of Sportingbet to be transferred to William Hill. As part of the GVC shares consideration, Sportingbet shareholders are being offered the opportunity to accept either these new GVC ordinary shares or a cash alternative of 233.5p per share. To the extent that a mix and match arrangement does not operate so as to deliver to any eligible Sportingbet shareholders the full amount of cash consideration for which they have elected, GVC has entered into a series of agreements whereby various parties have agreed to subscribe new GVC ordinary shares to underpin the cash consideration elected for by Sportingbet shareholders. Antisoma has entered into such an agreement with GVC to subscribe up to 1,713,062 new GVC ordinary shares at 233.5p per share, which represents a total potential commitment of GBP4.0 million. 1,713,062 new GVC ordinary shares would represent approximately 2.8 per cent. of GVC's issued ordinary share capital assuming full acceptance of the Offer. As consideration for this commitment, Antisoma has been granted subscription options over a further 343,053 new GVC ordinary shares, which are exercisable at 233.5p per share until the third anniversary from the date of grant. Antisoma's commitment continues until the earlier of the date on which the Offer is declared wholly unconditional or 30 June 2013. Antisoma will make a further announcement as soon as possible thereafter as to the number of new GVC ordinary shares subscribed under this agreement. In the 6 months ended 30 June 2012, GVC made a profit before taxation of Euro 5.2 million on revenue of Euro 29.1 million (Year ended 31 December 2011, loss before tax of Euro 0.14 million on revenue of Euro 44.34 million). Its net assets at 30 June 2012 amounted to Euro 57.98 million. Further information on the Offer, GVC and Sportingbet is set out in the announcement of the Offer of today's date. Contacts: Antisoma plc | leedskier | |
07/12/2012 16:09 | nice up channel since august. is anybody out there ? | mrsapeslaptop | |
17/9/2012 16:54 | Hello....??? Up 12% today.......... | palwing8 | |
12/9/2012 17:01 | Another month passes with no news at all. Great work if you can get it. | jsbach123 | |
19/8/2012 14:12 | I would be happy if they used all of the cash to buy shares in Scancell Holdings | red army | |
19/8/2012 13:58 | I think it is a not unreasonable expectation from shareholders that such management that remain and draw salaries from company funds could issue some sort of news statement, or turn the company into a closed tracker fund (or better still wind the company up and return what little remains to shareholders). | jsbach123 | |
14/8/2012 08:35 | Spending money on directors remuneration.. | fenners66 | |
11/8/2012 18:17 | Anybody know what on earth Antisoma are doing now? | dbharrison1 | |
11/7/2012 20:57 | There are convincing arguments that when a company clearly has failed but still has some assets to wind it up and return whatever value there is left to shareholders. Or if that is too complex and majority shraeholders are desperate to keep it trading perhaps ASM should reinvent itself as a tracker fund - more profitable probably johnsmith than the 'range of smaller investments' you envisage. | jsbach123 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions